All terms in DRUGBANK

Label Id Description
AZD-6280 DB12210 [AZD6280 has been used in trials studying the basic science of Anxiety.]
Bevonium DB13542
PSI-697 DB12211 [PSI-697 has been used in trials studying the treatment of Scleritis.]
Lucerastat DB14872 [Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease).]
Nevirapine DB00238 [A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. [PubChem] Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.]
Formebolone DB01569 [Formebolone, a derivative of androstane, is an anabolic androgenic steroid. It is on the list of substances prohibited by the Word Anti-Doping Agency, and is regularly screened for in athletes.[A14416] It is also classified by the US Drug Enforcement Administration as Schedule III drug in the Controlled Substances Act. It has been used experimentally in the treatment of growth retardation, and has been noted to increase bone mass.[A14416] Additionally, it has been patented for use in development of novel transdermal delivery systems for enhanced drug delivery.]
Codeine-N-oxide DB01568
Butabarbital DB00237 [Butabarbital (trade name Butisol) is a barbiturate with a particularly fast onset of effects and short duration of action compared to other barbiturates. This makes butabarbital a useful drug for certain applications such as treating severe insomnia and relieving anxiety before surgical procedures. However, like other barbiturate drugs, butabarbital is associated with profound CNS depressant effects, especially when combined with alcohol, as well as the risk of drug misuse and dependence. While its clinical use is typically limited, it is still prescribed in some Eastern European and South American countries. Its short duration of action gives butabarbital a high abuse potential, comparable to [secobarbital].]
N-Carboxymethionine DB02899
Oxiconazole DB00239 [Oxiconazole is an antifungal agent that is commonly found in topical formulations. It is marketed under the brand names Oxistat and Oxistat, and is used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm.]
Acetylphosphate DB02897
Reboxetine DB00234 [Reboxetine is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Reboxetine has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine.]
Dihydromorphine DB01565 [A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential. [PubChem]]
(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone DB02898
Aminosalicylic acid DB00233 [An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.]
Calusterone DB01564 [A 17-alkylated orally active androgenic steroid. A Schedule IV drug in Canada.]
Pipobroman DB00236 [An antineoplastic agent that acts by alkylation.]
Fludiazepam DB01567 [Fludiazepam is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a scheduled drug in the U.S., but is approved for use in Japan.]
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol DB02895
Methylthioinosine DB02896 [An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.]